Evidence method
Level · gp.fundamentals.capex_revenue_ratio
6.51% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HUMA · Sep 30, 2025
Humacyte, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001818382-25-000132General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-3174.50% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
2445.95% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
65.47% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-3239.04% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2293.89% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
333.33% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History6 statesHistory building
Period transition
What moved in the state?
- Previous
- 188.70%
- Current
- 6.51%
- Delta
- -182.20%
- Previous
- -8775.08%
- Current
- -3174.50%
- Delta
- 5600.58%
- Previous
- 3676.74%
- Current
- 2445.95%
- Delta
- -1230.79%
- Previous
- 29.24%
- Current
- 65.47%
- Delta
- 36.24%
- Previous
- -9876.08%
- Current
- -3239.04%
- Delta
- 6637.04%
- Previous
- 7310.96%
- Current
- 2293.89%
- Delta
- -5017.07%
- Previous
- 808.64%
- Current
- 333.33%
- Delta
- -475.30%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · HUMA Fundamental State →Has State · Humacyte, Inc. →Transitioned To · HUMA Fundamental State →Transitioned To · HUMA CAPEX_INTENSITY_DECREASED →Transitioned To · HUMA CASH_GENERATION_INCREASED →Transitioned To · HUMA INVENTORY_PRESSURE_DECREASED →Transitioned To · HUMA MARGIN_INCREASED →Transitioned To · HUMA PROFITABILITY_INCREASED →Transitioned To · HUMA R_AND_D_INTENSITY_DECREASED →Transitioned To · HUMA SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.